News for 'Food and Drugs Administration'

Tirupati laddu row: Food safety regulator notice to ghee supplier

Tirupati laddu row: Food safety regulator notice to ghee supplier

Rediff.com23 Sep 2024

The controversy has sparked reactions across states. The famous Mankameshwar temple in Uttar Pradesh has now banned offerings of 'prasad' bought by devotees from outside and said they can offer homemade 'prasad' or fruits.

Phone Use on Toilet Linked To Piles

Phone Use on Toilet Linked To Piles

Rediff.com24 Feb 2025

The habit, coupled with a sedentary lifestyle and poor diet, is putting increased strain on the rectal area, leading to painful conditions that often require medical intervention.

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Trump threatens steeper tariffs on India over Russian oil buy

Trump threatens steeper tariffs on India over Russian oil buy

Rediff.com4 Aug 2025

"India is not only buying massive amounts of Russian Oil, they are then, for much of the Oil purchased, selling it on the Open Market for big profits," Trump said in a social media post on Monday.

Tirupati laddu row: Govt to wait for FSSAI report before action

Tirupati laddu row: Govt to wait for FSSAI report before action

Rediff.com23 Sep 2024

Amid the ongoing controversy over Tirupati laddu, Consumer Affairs Secretary Nidhi Khare on Monday said her department will consider additional measures to monitor ghee quality in the market only after receiving the Food Safety and Standards Authority of India (FSSAI) report.

Sun Pharma recalls over 34k bottles of generic drug in US

Sun Pharma recalls over 34k bottles of generic drug in US

Rediff.com11 Feb 2023

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. As per the US Food and Drug Administration's Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

Maha portfolio allocation: Fadnavis gets Home, Ajit Finance, Shinde...

Maha portfolio allocation: Fadnavis gets Home, Ajit Finance, Shinde...

Rediff.com21 Dec 2024

Shiv Sena's Dadaji Bhuse is the new school education minister while Uday Samant continues to be the industries minister.

Display owner's name, install cameras: UP govt cracks down on eateries

Display owner's name, install cameras: UP govt cracks down on eateries

Rediff.com24 Sep 2024

Taking cognisance of incidents of spitting and mixing of urine in eatables in Uttar Pradesh, Chief Minister Yogi Adityanath on Tuesday directed that the name and address of operators, proprietors and managers should be mandatorily displayed at all food centres.

Checks On Drug-Making Units Begins

Checks On Drug-Making Units Begins

Rediff.com29 Dec 2022

The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country

US: Indian couple sentenced for using unapproved cancer drugs

US: Indian couple sentenced for using unapproved cancer drugs

Rediff.com14 Jun 2014

A United States court has sentenced an Indian oncologist and his wife for using unapproved chemotherapy medications at their cancer institute for three years.

Nigeria flags 2 India-made drugs as substandard, having toxins

Nigeria flags 2 India-made drugs as substandard, having toxins

Rediff.com20 Jun 2023

Oral paracetamol and another cough medicine manufactured by companies based in Mumbai and Punjab were found to be "sub-standard or found to be containing toxins", reports Sohini Das.

US drug shortage a shot in the arm for Indian pharmaceutical companies

US drug shortage a shot in the arm for Indian pharmaceutical companies

Rediff.com26 Jun 2023

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Nuvama Research analysts said that US price erosion seems to have normalised to its old levels of 6-8 per cent and volumes are picking up with easing of inventory. Similarly, an ICICIdirect analyst noted: "Price erosion intensity has now moderated to a single digit and is expected to tone down a

Equity market volatility may persist; long-term outlook remains constructive: Experts

Equity market volatility may persist; long-term outlook remains constructive: Experts

Rediff.com3 Apr 2025

The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts said on Thursday. The US has announced 27 per cent reciprocal tariffs on India, citing high import duties imposed by New Delhi on American goods.

Recent drug recalls worry investors

Recent drug recalls worry investors

Rediff.com19 Mar 2013

Many say trend could lead to concerns on manufacturing quality in Indian facilities.

Indian drug firm recalls eye drop linked to vision loss in US

Indian drug firm recalls eye drop linked to vision loss in US

Rediff.com3 Feb 2023

Global Pharma Healthcare is recalling entire lots of eye drop linked to vision loss in the US, according to the US Food and Drug Administration. The Chennai-based company is recalling all lots of artificial tears lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma to the consumer level due to possible contamination, the US health regulator said in a statement. "The Centres for Disease Control and Prevention (CDC) alerted FDA to an investigation of a multi-state cluster of Verona Integron-mediated Metallo--lactamase (VIM)- and Guiana-Extended Spectrum--Lactamase (GES)- producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections possibly associated with the use of the artificial tears manufactured by Global Pharma Healthcare," USFDA said.

Dead snake found in mid-day meal packet in Sangli

Dead snake found in mid-day meal packet in Sangli

Rediff.com4 Jul 2024

A tiny dead snake was allegedly found in a packet distributed under the mid-day meal scheme meant for children aged between six months and three years at an anganwadi or a government-run nursery school in western Maharashtra's Sangli district, prompting the authorities to launch a probe.

Trump's tariffs: How will these sectors in India be impacted?

Trump's tariffs: How will these sectors in India be impacted?

Rediff.com2 Apr 2025

Goods from sectors, including agriculture, precious stones, chemicals, pharma, medical devices, electricals, and machinery may get impacted if the US will go ahead with imposing reciprocal tariffs on Indian products, according to experts. They said that these sectors could face additional customs duties from the Trump administration because of the high tariff differential or gap, which is the difference between the import duties imposed by the US and India on a product.

Natco medicine gets 'Orphan Drug' status

Natco medicine gets 'Orphan Drug' status

Rediff.com29 Mar 2011

Natco Pharma's anti-cancer drug, NRC-AN-019, has received 'Orphan Drug' designation from the US Food and Drug Administration (USFDA) for three indications - glioma (brain tumour), pancreatic cancer and chronic myelogenous leukemia.

New rules for Indian generic drug makers

New rules for Indian generic drug makers

Rediff.com29 Oct 2012

Regulator says fee would enable it to quicken approval process.

USTR Report Intensifies Trade Tensions With India

USTR Report Intensifies Trade Tensions With India

Rediff.com2 Apr 2025

The US Trade Representative noted that India's average applied tariff rate stood at 17% per cent, the highest of any major world economy.

The Coming Dementia Epidemic

The Coming Dementia Epidemic

Rediff.com20 Dec 2024

Around 7.4 per cent of Indians aged 60 and above are affected by dementia. This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase.

USFDA nods Ranbaxy drug

USFDA nods Ranbaxy drug

Rediff.com23 Sep 2004

Ranbaxy Laboratories Ltd said on Thursday that it has bagged the US Food and Drug Administration's approval for manufacturing and marketing Loratadine and Pseudoephedrine Sulfate Extended-release tablets.

'Zero-For-Zero Tariff Is Best Medicine For India'

'Zero-For-Zero Tariff Is Best Medicine For India'

Rediff.com21 Apr 2025

'No retaliatory tariffs now. You can retaliate after a few months.' 'Today, there is no need to retaliate because it is a question of long term benefits.'

FDA diktat on 'wonder' drugs

FDA diktat on 'wonder' drugs

Rediff.com20 Apr 2005

Alarmed by the growing number of advertisements on 'miracle' drugs being shown on television channels, Maharashtra Food and Drug Administration

Standards violation: FDA seizes Caraco drugs

Standards violation: FDA seizes Caraco drugs

Rediff.com26 Jun 2009

The US Food and Drug Administration has seized drug products manufactured by Caraco Pharmaceutical, at the company's Michigan facilities in Detroit, Farmington Hills, and Wixom, the US FDA said on Thursday. The FDA seeks to immediately stop Caraco from further distributing drugs until there is assurance that the firm complies with good manufacturing requirements, it added.

US food regulator testing Maggi noodles after India recall

US food regulator testing Maggi noodles after India recall

Rediff.com11 Jun 2015

Nestle, the world's largest food company, is seeking to defend its reputation in India after it pulled Maggi noodles from stores.

Why US doctors want Indian drugs to be banned

Why US doctors want Indian drugs to be banned

Rediff.com24 Mar 2014

In the final part of a three-part series on America's war on substandard Indian generic drugs, Aziz Haniffa speaks about American doctors' contempt for drugs exported from India and the ineptitude of the US Food and Drug Administration to stop the menace.

Are Indian drugs safe? US doctors worried over quality

Are Indian drugs safe? US doctors worried over quality

Rediff.com18 Mar 2014

Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

The Many Portfolios Of Yogi Adityanath

The Many Portfolios Of Yogi Adityanath

Rediff.com4 Apr 2022

In his second term in office, UP Chief Minister Yogi Adityanath has retained 34 portfolios.

Ranbaxy bags cardio drug deal

Ranbaxy bags cardio drug deal

Rediff.com10 Dec 2004

Dr Reddy's files second NDA in US

Dr Reddy's files second NDA in US

Rediff.com27 Jun 2003

Watson sends patent challenge notice to Ranbaxy for acne drug

Watson sends patent challenge notice to Ranbaxy for acne drug

Rediff.com20 Sep 2013

The drug is licensed to Ranbaxy Laboratories from Cipher Pharmaceuticals Inc of Mississauga, Ontario. It is currently protected by two issued patents listed in the FDA's approved drug products list, which expire in September 2021, the company said in a statement.

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Rediff.com9 Mar 2024

The Narcotics Control Bureau (NCB) on Saturday said it has arrested Jaffer Sadiq, a Tamil Nadu-based alleged dealer of narcotics, in connection with an international drugs trafficking investigation case.

China apologises to Nigeria over fake drugs

China apologises to Nigeria over fake drugs

Rediff.com21 Sep 2009

China has formally apologised to Nigeria for alleged export of fake drugs including some labelled as 'Made in India' by some Chinese firms to the country and assured to take punitive action against those involved in the scandal.

Indian majors lead race for US drug ingredient market

Indian majors lead race for US drug ingredient market

Rediff.com30 Jan 2013

In 2012, drugs worth $35 billion went off-patent in the US, while the market size of drugs which will see patent expiry in 2013 will halve to $17 billion.

Maharashtra drug body cracks down on misleading ads

Maharashtra drug body cracks down on misleading ads

Rediff.com7 May 2012

The Maharashtra Food and Drugs Administration has initiated action against manufacturers of medicines and instruments, newspapers, TV channels and cable operators making outrageous claims through advertisements.

Wockhardt gets USFDA nod for cardiac drug

Wockhardt gets USFDA nod for cardiac drug

Rediff.com16 Aug 2012

Wockhardt said it is launching the product immediately in the US market.

Now, Ranbaxy AIDS drug under US lens

Now, Ranbaxy AIDS drug under US lens

Rediff.com22 Sep 2008

It is now probing the quality of AIDS medicines supplied by the company to developing countries under US government-funded programmes. Estimates suggest that Ranbaxy has received over $9 million from the programme so far. Ranbaxy had a turnover of $1.5 billion in 2007-08, of which a quarter came from US sales.